Supplementary Table 1.
Cytokine Detection Assays in Patients Infected With SARS-CoV-2
| Characteristic | Patients (n = 30) | Diarrhea group (n = 15) | Non-diarrhea group (n = 15) | P value |
|---|---|---|---|---|
| IL2 (pg/mL; normal range 0.10–4.10) | 2.41 ± 0.30 | 2.26 ± 0.27 | 2.59 ± 0.24 | .001 |
| IL4 (pg/mL; normal range 0.10–3.20) | 1.80 ± 0.49 | 1.54 ± 0.37 | 2.11 ± 0.44 | .001 |
| IL6 (pg/mL; normal range 0.10–2.90) | 13.27 ± 15.16 | 15.87 ± 18.78 | 10.10 ± 9.16 | .294 |
| Increased, n (%) | 27 (90) | 13 (87) | 14 (93) | >.999 |
| IL10 (pg/mL; normal range 0.10–5.00) | 4.62 ± 2.59 | 3.84 ± 1.64 | 5.57 ± 3.27 | .078 |
| Increased, n (%) | 8 (27) | 3 (20) | 5 (33) | .682 |
| TNF-α (pg/mL; normal range 0.10–23.00) | 2.41 ± 1.90 | 2.68 ± 2.56 | 2.08 ± 0.36 | .376 |
| IFN-γ (pg/mL; normal range 0.10–18.00) | 2.33 ± 1.02 | 1.90 ± 0.49 | 2.85 ± 1.27 | .012 |
IFN, interferon; IL, interleukin; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TNF, tumor necrosis factor.